| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/09/2009 | WO2009048940A3 Diacerein pharmaceutical formulations |
| 07/09/2009 | WO2009047321A3 A sublingual effervescent tablet of progesterone associated with cyclodextrin |
| 07/09/2009 | WO2009036851A3 Use of microcapsules and microcapsule |
| 07/09/2009 | WO2009009562A3 Glp-1-fc fusion protein formulation |
| 07/09/2009 | WO2008083192A8 Methods and formulations for improved bioavailability of antiprogestins |
| 07/09/2009 | US20090176884 Pharmaceutical suspension composition |
| 07/09/2009 | US20090176872 Carotenoid Composition and Method for Protecting Skin |
| 07/09/2009 | US20090176852 Temozolomide FDA Orange book listed patent; water soluble, and storage stable formulation; L-threonine as dissolution enhancer |
| 07/09/2009 | US20090176814 Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
| 07/09/2009 | US20090176750 Specified ratio of penetration enhancers to solvents and emulsifiers; fluocinolone |
| 07/09/2009 | US20090176250 Immunoliposome-Nucleic Acid Amplification (ILNAA) Assay |
| 07/09/2009 | US20090176099 Nonbreaking coating for hydrogel, such as polyurethane; for absorbent disposable articles such as diapers; example of coating materials are those known by the tradenames Hystretch, Vinamul, Dur-O-Set Elite, Rovene, GenFlo, AcryGen and Suncryl |
| 07/09/2009 | US20090176005 Method And Apparatus For Spray Processing Of Porous Medical Devices |
| 07/09/2009 | US20090175953 Nanodispersions |
| 07/09/2009 | US20090175952 Cefuroxime axetil granule and process for the preparation thereof |
| 07/09/2009 | US20090175951 Nanoparticulate compositions of immunosuppressive agents |
| 07/09/2009 | US20090175950 Pharmaceutical safety dosage forms |
| 07/09/2009 | US20090175949 Microparticles for delivery to cells and/or tissues |
| 07/09/2009 | US20090175948 Aerosol method for nano silver-silica composite anti-microbial agent |
| 07/09/2009 | US20090175947 Pharmaceutical composition for injectional particularly targeted local administration |
| 07/09/2009 | US20090175946 Use of gelatin and a cross-linking agent for producing cross-linking medical glues |
| 07/09/2009 | US20090175945 Systems, Methods, and Formulations for Topically Treating Nail Fungal Infections and Nail Psoriasis |
| 07/09/2009 | US20090175944 Gel suitable for implantation and delivery system |
| 07/09/2009 | US20090175943 Transdiscal administration of specific inhibitors of pro-inflammatory cytokines |
| 07/09/2009 | US20090175942 Solid Dosage Form of Olmesartan Medoxomil And Amlodipine |
| 07/09/2009 | US20090175941 Tablet-form slow-release preparation for vertigo |
| 07/09/2009 | US20090175940 Solubilized ibuprofen |
| 07/09/2009 | US20090175939 Pharmaceutical compositions |
| 07/09/2009 | US20090175938 Controlled Release Flurbiprofen and Muscle Relaxant Combinations |
| 07/09/2009 | US20090175937 Misuse Preventative, Controlled Release Formulation |
| 07/09/2009 | US20090175936 Microtablet-Based Pharmaceutical Preparation |
| 07/09/2009 | US20090175935 Pharmaceutical compositions of duloxetine |
| 07/09/2009 | US20090175934 Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same |
| 07/09/2009 | US20090175933 Preparation for the treatment of diarrhoea |
| 07/09/2009 | US20090175932 Micelle assemblies |
| 07/09/2009 | US20090175931 Compositions and methods for modulating hemostasis |
| 07/09/2009 | US20090175930 Composition Suppressing The Expression of Target Gene in Eyeball and Medicament For Treating of Disease in Eyeball |
| 07/09/2009 | US20090175929 Transdermally absorbable Donepezil Preparation |
| 07/09/2009 | US20090175928 Lip Plaster |
| 07/09/2009 | US20090175927 Administration of cells and cellular extracts for rejuvenation |
| 07/09/2009 | US20090175926 Topical burn treatment |
| 07/09/2009 | US20090175918 Ultra-Passivation of Chromium-Containing Alloy and Methods of Producing Same |
| 07/09/2009 | US20090175914 Salts or Complexes of Methyl Donors With Phytic Acid or Its Derivatives and Method for the Synthesis Thereof |
| 07/09/2009 | US20090175910 Modifications of HIV Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175883 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
| 07/09/2009 | US20090175803 Method and compositions for administering resveratrol and pterostilbene |
| 07/09/2009 | US20090175802 Tiotropium containing hfc solution formulations |
| 07/09/2009 | US20090175801 Cns-tumor treatment method and composition |
| 07/09/2009 | US20090175800 Methods and Compositions For P2X Receptor Calcium Entry Channels and Other Calcium Entry Mechanisms |
| 07/09/2009 | US20090175799 Colored or colorable topical composition foam |
| 07/09/2009 | US20090175785 Self-Assembled Fmoc-Ff Hydrogels |
| 07/09/2009 | US20090175784 Anti-Alpha V Immunoliposome Composition, Methods, and Uses |
| 07/09/2009 | DE112006001606T5 Nanopartikuläre und eine kontrollierte Freisetzung aufweisende Zusammensetzung, die Cefditoren umfassen Nanoparticulate, and having a controlled release composition comprising cefditoren |
| 07/09/2009 | DE102008003453A1 Verfahren zur Herstellung poröser Mikrostrukturen, nach diesem Verfahren hergestellte poröse Mikrostrukturen sowie deren Verwendung A process for the production of porous microstructures, porous microstructures produced by this process and the use thereof |
| 07/09/2009 | CA2711211A1 Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
| 07/09/2009 | CA2711187A1 Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders |
| 07/09/2009 | CA2711001A1 Biocompatible protein-based particles and methods thereof |
| 07/09/2009 | CA2710775A1 Formulation |
| 07/09/2009 | CA2710762A1 Recombinant vwf formulations |
| 07/09/2009 | CA2710713A1 Silencing of polo-like kinase expression using interfering rna |
| 07/09/2009 | CA2710271A1 Enhancing photostabilization of oxymetazoline |
| 07/09/2009 | CA2710241A1 Compositions and methods for reducing or preventing water loss from the skin |
| 07/09/2009 | CA2710227A1 Treatment of surgical adhesions |
| 07/09/2009 | CA2710223A1 Treatment of surgical adhesions |
| 07/09/2009 | CA2709993A1 Amphiphilic block copolymer micelle composition containing taxane and manufacturing process of the same |
| 07/09/2009 | CA2709950A1 Pharmaceutical composition |
| 07/09/2009 | CA2709899A1 Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes |
| 07/09/2009 | CA2709875A1 Improved compositions and methods for the delivery of nucleic acids |
| 07/09/2009 | CA2709781A1 Counter-pressure filtration of proteins |
| 07/09/2009 | CA2709712A1 Process for preparing microparticles having a low residual solvent volume |
| 07/09/2009 | CA2709709A1 Manufacture of tablet |
| 07/09/2009 | CA2709545A1 Topical application and formulation of erythropoietin for skin wound healing |
| 07/09/2009 | CA2709227A1 Stable elsamitrucin salt formulations |
| 07/09/2009 | CA2708627A1 High concentration antibody-containing liquid formulation |
| 07/09/2009 | CA2708400A1 A slow-release formulation based on an association of glycogen and alginate |
| 07/09/2009 | CA2701789A1 Novel taxoid-based compositions |
| 07/08/2009 | EP2077126A1 Analgesic apatitic calcium-phosphate cement |
| 07/08/2009 | EP2077114A1 Pharmaceutical preparation for treating fibromyalgia |
| 07/08/2009 | EP2077107A1 Calcium-containing structures and methods of making and using the same |
| 07/08/2009 | EP2077106A1 W/o/w emulsion composition |
| 07/08/2009 | EP2077105A1 Ophthalmic Micellar Compositions with Enhanced Stability |
| 07/08/2009 | EP2077104A1 Micellar compositions with ophtalmic applications |
| 07/08/2009 | EP2076313A2 Gels with predetermined conductivity used in irreversible electroporation of tissue |
| 07/08/2009 | EP2076251A2 Non-mucoadhesive film dosage forms |
| 07/08/2009 | EP2076250A2 Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations |
| 07/08/2009 | EP2076249A2 Dry granulation binders, products, and use thereof |
| 07/08/2009 | EP2076248A2 Methods and compositions for controlling the bioavailability of poorly soluble drugs |
| 07/08/2009 | EP2076247A2 A self-gelling tunable drug delivery system |
| 07/08/2009 | EP2076246A1 Formation of medically useful gels comprising microporous particles and methods of use |
| 07/08/2009 | EP2076245A2 Lysine-based polymeric linkers |
| 07/08/2009 | EP2076244A2 Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof |
| 07/08/2009 | EP2076243A1 Liquid formulation of g-csf |
| 07/08/2009 | EP2076242A2 Aerosolizable formulation comprising insulin for pulmonary delivery |
| 07/08/2009 | EP2076241A2 Fibrous calcium pyrophosphate particles and methods of making and using same |
| 07/08/2009 | EP2076173A2 Burst suppression monitor for induced coma |
| 07/08/2009 | EP2076131A1 Process for preparing oxymorphone, naltrexone, and buprenorphine |
| 07/08/2009 | EP1667667A4 Hydrogel compositions with an erodible backing member |
| 07/08/2009 | EP1660048A4 Method for deterring abuse of opioids by combination with non-release formulation of emetic |
| 07/08/2009 | EP1547170A4 Method for manufacture of films containing insoluble solids embedded in cellulose-based films |